The proteomic mechanisms by which AgNPs exert their antimicrobial effects are investigated, with a special focus on their activity against planktonic bacteria and in biofilms and the issue of resistance to antibiotics is addressed.
A framework to be followed during preclinical investigation of nanomedicines to increase their translatability potential is proposed and will help accelerate the clinical translation and maximize the impact of nanomedicines.
An assessment of the current state of microfluidic technologies for lipid-based nanoparticle and nanomedicine production is presented, with an emphasis on the capabilities of microfluidic systems for controlling nanoparticle size and size distribution.
Article Galaxy Pages is a free service from Research Solutions, a company that offers access to content in collaboration with publishing partners, online repositories and discovery services.